Treatment
Standard care clinical trials
We’re tracking 1,103 recruiting studies that include Standard care, each written for real people, not researchers, below.
Recruiting studies
- NCT06927635RecruitingPhase 2
SBRT vs standard care for prostate cancer that has spread to a few spots
This trial tests whether targeted radiation (SBRT) to a few sites of cancer spread can help men whose prostate cancer has stopped responding to hormone therapy but has not spread to many places. You may benefit if you have a limited number of growing spots outside the brain or spine.
Toronto, OntarioAges 18–100 - NCT06923046Recruiting
Team Clinic for teens with type 2 diabetes
This trial tests a group clinic program for teens with type 2 diabetes. It aims to help you manage your diabetes better with support from others your age and your family.
Los Angeles, CaliforniaAges 12–18 - NCT06925321RecruitingPhase 3
Testing Fosmanogepix for Serious Mold Infections
This trial tests a new drug, Fosmanogepix, for treating serious mold infections that are hard to treat with current medicines. It may be an option for people with limited treatment choices.
Birmingham, AlabamaAges 18 years+ - NCT06918002RecruitingPhase 3
Comparing elranatamab with standard care for newly diagnosed multiple myeloma
This trial tests if adding the immunotherapy drug elranatamab (with or without lenalidomide) after initial treatment works better than the usual care for people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant.
BrusselsAges 18–69 - NCT06915363Recruiting
BioPoly implant for knee cartilage repair
This trial tests a BioPoly implant to repair a small damaged cartilage spot in your knee. If you have a specific type of cartilage injury that didn't get better with other treatments, this implant may help relieve pain and improve function.
Fort Wayne, IndianaAges 30–65 - NCT06918561Recruiting
NeoThelium FT for chronic open wounds
This trial tests a new skin-like graft called NeoThelium FT to see if it helps chronic open wounds heal faster. It is for adults with a non-infected wound that has been open for at least 4 weeks and is not a diabetic, pressure, or burn wound.
Denham Springs, LouisianaAges 18 years+ - NCT06921707Recruiting
WounDx test for healing decisions in large wounds
This trial tests a new tool called WounDx that helps doctors decide the best way to treat large wounds on arms, legs, or buttocks. It may help your wound heal better by guiding your care.
Birmingham, AlabamaAges 18–65 - NCT06914999RecruitingEarly Phase 1
Comparing a new scan to standard scan during head and neck cancer radiation
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Atlanta, GeorgiaAges 18 years+ - NCT06917651RecruitingPhase 3
Study of a new pain medicine for arm or leg injuries in the ER
This trial tests a fast-acting pain pill (sufentanil) placed under the tongue for people with moderate to severe pain from a single arm or leg injury. It aims to see if it works well in the emergency room.
FranceAges 18 years+ - NCT06912763RecruitingPhase 2
Reversing radiation side effects in head and neck cancer
This trial tests a combined treatment (a statin and a drug that helps blood flow) to reverse long-term swelling and tissue hardening caused by head and neck radiation. It may help people who have had these side effects for more than 6 months.
Houston, TexasAges Any age - NCT06906926Recruiting
Studying the Harmony heart valve for long-term safety
This study is following people who get the Harmony valve to see how well it works over time. The valve helps blood flow from the heart to the lungs in people with certain heart conditions.
CopenhagenAges Any age - NCT06907446Recruiting
New SUREcore needle vs standard care for prostate biopsy
This trial compares a new biopsy needle called SUREcore to the standard needle used during prostate biopsies. It aims to see if the SUREcore needle works better or causes less discomfort.
Sacramento, CaliforniaAges 18 years+ - NCT06905509RecruitingPhase 2
Epcoritamab with chemo and stem cell transplant for large B-cell lymphoma
This trial tests adding epcoritamab (an immune therapy that helps your body fight cancer) to standard chemotherapy followed by a stem cell transplant. It is for people with large B-cell lymphoma that has come back or not responded to initial treatment.
Sacramento, CaliforniaAges 18 years+ - NCT06908213Recruiting
Enhanced recovery after surgery for teen scoliosis
This trial tests a special program to help teens recover faster after scoliosis surgery. It focuses on better pain control, shorter hospital stays, and getting back to normal activities sooner.
AmiensAges 11–17 - NCT06890598RecruitingPhase 3
Study of olomorasib for KRAS G12C-mutant lung cancer
This trial tests a new targeted therapy (olomorasib) combined with standard treatments for people with a specific type of non-small cell lung cancer that has a KRAS G12C mutation. Depending on the stage of your cancer, you may receive it before or after surgery, or along with chemotherapy and radiation.
Huntsville, AlabamaAges 18 years+ - NCT06892158Recruiting
Massage therapy for sleep in teens with cancer
This trial studies if massage therapy can help teenagers and young adults with cancer sleep better while they are in the hospital. Participants will receive massage sessions and answer questions about their sleep.
Washington D.C., District of ColumbiaAges 12–21 - NCT06880224Recruiting
HIV prevention and treatment for Nigerian youth aged 15-24
This study tests better ways to find and treat HIV in young people (ages 15-24) in Nigeria. It offers either HIV prevention medicine (PrEP) if you are HIV-negative, or HIV treatment if you are newly diagnosed with HIV.
Uyo, Akwa Ibom StateAges 15–24 - NCT06873698Recruiting
Neurobehavioral therapy trial for functional movement disorder
This study tests a type of talk therapy called neurobehavioral therapy (NBT) to help people with functional movement disorder. It aims to see if this therapy can improve symptoms and quality of life.
Providence, Rhode IslandAges 18–100 - NCT06871176Recruiting
New PET/MR scan vs standard imaging for multiple myeloma
This trial compares a new type of PET/MR scan (using a radioactive tracer called Ga-68 PentixaFor) with standard imaging to see if it can better detect multiple myeloma at diagnosis and during follow-up. It may help improve staging and treatment planning.
Toronto, OntarioAges 18 years+ - NCT06874413Enrolling by invitation
Exercise program for frail older adults before hernia surgery
This study tests whether a supervised exercise program before hernia repair surgery helps frail older adults recover better. The program includes physical exercises and breathing muscle training.
Greenville, South CarolinaAges 65 years+ - NCT06873659RecruitingPhase 1
Testing SON-DP for advanced solid tumors
This trial tests a new drug called SON-DP for people with advanced solid tumors that haven't responded to standard treatments. It aims to see if the drug is safe and helps shrink or control the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06877884Recruiting
Cancer care data collection registry
This trial gathers information from your routine cancer care to help researchers learn more about real-world treatments and outcomes. No extra tests or procedures are required.
Monterey, CaliforniaAges 18–120 - NCT06868537Recruiting
Launching! to Adulthood program for teens with autism
This study tests a program called Launching! to Adulthood, which is designed to help teens and young adults with autism spectrum disorder (ASD) prepare for adult life. You and a parent would take part in the program together.
Houston, TexasAges 18–25 - NCT06860334RecruitingPhase 2
Testing treatments for Crimean-Congo hemorrhagic fever
This trial tests different treatments for Crimean-Congo hemorrhagic fever (CCHF), a serious viral infection. It aims to find which treatment is safe and works best for patients who are hospitalized with the disease.
ErzurumAges 18 years+
Common questions
- Are there clinical trials studying Standard care?
- Yes. Clin2 currently lists 1,103 recruiting studies that include Standard care, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Standard care trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Standard care an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Standard care or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.